Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 1
1980 1
1984 2
1985 4
1986 4
1987 2
1988 3
1989 3
1990 5
1991 4
1992 4
1993 4
1994 2
1995 1
1996 1
1997 2
1998 2
1999 6
2000 3
2001 2
2002 6
2003 1
2004 3
2007 2
2009 1
2010 1
2011 3
2012 2
2013 1
2014 3
2015 1
2016 10
2017 7
2018 5
2019 2
2020 4
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study.
von der Maase H, Hansen SW, Roberts JT, Dogliotti L, Oliver T, Moore MJ, Bodrogi I, Albers P, Knuth A, Lippert CM, Kerbrat P, Sanchez Rovira P, Wersall P, Cleall SP, Roychowdhury DF, Tomlin I, Visseren-Grul CM, Conte PF. von der Maase H, et al. Among authors: hansen sw. J Clin Oncol. 2000 Sep;18(17):3068-77. doi: 10.1200/JCO.2000.18.17.3068. J Clin Oncol. 2000. PMID: 11001674 Corrected and republished. Clinical Trial.
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study.
von der Maase H, Hansen SW, Roberts JT, Dogliotti L, Oliver T, Moore MJ, Bodrogi I, Albers P, Knuth A, Lippert CM, Kerbrat P, Sanchez Rovira P, Wersall P, Cleall SP, Roychowdhury DF, Tomlin I, Visseren-Grul CM, Conte PF. von der Maase H, et al. Among authors: hansen sw. J Clin Oncol. 2023 Aug 10;41(23):3881-3890. doi: 10.1200/JCO.22.02763. J Clin Oncol. 2023. PMID: 37549482
Neurotoxicity secondary to antineoplastic drugs.
Tuxen MK, Hansen SW. Tuxen MK, et al. Among authors: hansen sw. Cancer Treat Rev. 1994 Apr;20(2):191-214. doi: 10.1016/0305-7372(94)90027-2. Cancer Treat Rev. 1994. PMID: 8156541 Review. No abstract available.
Lectin complement pathway proteins in healthy individuals.
Troldborg A, Hansen A, Hansen SW, Jensenius JC, Stengaard-Pedersen K, Thiel S. Troldborg A, et al. Among authors: hansen sw. Clin Exp Immunol. 2017 Apr;188(1):138-147. doi: 10.1111/cei.12909. Epub 2017 Jan 18. Clin Exp Immunol. 2017. PMID: 27925159 Free PMC article.
Real-world evidence to guide healthcare policies in oncology.
Donia M, Hansen SW, Svane IM. Donia M, et al. Among authors: hansen sw. Oncotarget. 2019 Jul 16;10(44):4513-4515. doi: 10.18632/oncotarget.27077. eCollection 2019 Jul 16. Oncotarget. 2019. PMID: 31360300 Free PMC article.
111 results